MiMedx Announces Wound & Surgical Product Pipeline Expansion On Agreement With Turn Therapeutics

Follow us on Google News:
 MiMedx Announces Wound & Surgical Product Pipeline Expansion On Agreement With Turn Therapeutics
Image source: ©2022 Kalkine Media®

Dec 8 (Reuters) - MiMedx Group Inc:


* MIMEDX ANNOUNCES WOUND & SURGICAL PRODUCT PIPELINE EXPANSION VIA IN-LICENSING AND DISTRIBUTION AGREEMENT WITH TURN THERAPEUTICS

* MIMEDX GROUP INC - AGREEMENT PROVIDES MIMEDX WITH EXCLUSIVE RIGHTS TO TURN'S PERMAFUSION® PROPRIETARY ANTIMICROBIAL INTELLECTUAL PROPERTY (IP)

* MIMEDX GROUP INC - UNDER TERMS OF AGREEMENT, CO HAS EXCLUSIVE RIGHTS TO DEVELOP FUTURE PRODUCTS FOR WOUND CARE, BURN, SURGICAL FIELDS USING TURN'S IP

* MIMEDX GROUP INC - TURN WILL RECEIVE AN UPFRONT CASH PAYMENT AND IS ENTITLED TO FUTURE PAYMENTS UPON MEETING OF REGULATORY, PRODUCT COMMERCIAL MILESTONES Source text for Eikon: Further company coverage:

Disclaimer

The above content is directly sourced from Reuters under a contractual arrangement. The content is being provided as a convenience and for informational purposes only; and does not constitute an endorsement or approval by Kalkine Media of any of the products, services, or opinions of the organization or individual. The user is apprised that Kalkine Media bears no responsibility for the accuracy, legality, or content of Reuters, any external sites, or for that of subsequent links. The user is requested to contact Reuters directly for answers to questions regarding the content. Please note that Kalkine Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Featured Articles